Technology | Cardiac Resynchronization Therapy Devices (CRT) | May 10, 2017

Biotronik Launches First FDA-Approved CRM Devices with MRI AutoDetect Technology

Technology allows patients greater access to MRI scans

Biotronik Launches First FDA-Approved CRM Devices with MRI AutoDetect Technology

May 10, 2017 —  Biotronik announced the availability of the first U.S. Food and Drug Administration (FDA)-approved cardiac rhythm management (CRM) devices with technology that automatically recognizes when a patient enters a magnetic resonance imaging (MRI) environment.

Biotronik's MRI AutoDetect technology ensures patients with CRM devices can safely undergo MRI scans while minimizing programming burdens for hospitals. Once activated by a physician, MRI AutoDetect can automatically recognize when the patient enters an MRI environment and convert the device to MRI mode. When the scan is complete, MRI AutoDetect automatically returns the device to its permanent program. Physicians can program MRI AutoDetect to be active for up to 14 days, allowing patients the flexibility to undergo, reschedule or repeat MRI scans as needed during the set timeframe.

MRI AutoDetect is currently available on Biotronik's newest line of CRM devices, including the Ilivia series for tachycardia.

The company will highlight its CRM solutions at the Heart Rhythm Society's (HRS) 38th Annual Scientific Sessions, May 10-13 in Chicago.

For more information: www.biotronik.com

Related Content

Abbott Announces MR-Conditional Labeling for Quadra Assura CRT-D and Fortify Assura ICD
Technology | Cardiac Resynchronization Therapy Devices (CRT) | January 03, 2018
Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for...
Biotronik Announces U.S. Launch of Edora HF-T QP CRT Pacemaker
Technology | Cardiac Resynchronization Therapy Devices (CRT) | August 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of Edora HF-T QP, an...
Biotronik Launches DX Technology for U.S. Heart Failure Patients
News | Cardiac Resynchronization Therapy Devices (CRT) | July 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and availability of the Intica DX and Intica...
Videos | Cardiac Resynchronization Therapy Devices (CRT) | May 23, 2017
This video, provided by ERB, demonstrates the function and implantation of the WiSE CRT (Wireless Stimulation Endocar
Biotronik Announces FDA Approval of MultiPole Pacing
Technology | Cardiac Resynchronization Therapy Devices (CRT) | May 11, 2017
May 11, 2017 — Biotronik announced U.S.
NICE Recommends Boston Scientific CRT-Ds With EnduraLife Battery Technology for Heart Failure Treatment
News | Cardiac Resynchronization Therapy Devices (CRT) | April 14, 2017
The National Institute for Health and Care Excellence (NICE) recently issued medical technology guidance recommending...
Biotronik, Edora series, pacemakers, CRT-Ps
Technology | Cardiac Resynchronization Therapy Devices (CRT) | March 23, 2017
March 23, 2017 — Biotronik announced the European launch of the Edora series, its smallest series of...
Medtronic, CRT-D, REVERSE Trial analysis, cost-effectiveness, Michael R. Gold, JACC Heart Failure
News | Cardiac Resynchronization Therapy Devices (CRT) | March 07, 2017
March 7, 2017 — Medtronic plc recently announced an economic analysis of five-year data showing that patients with mi
Overlay Init